Skip to main content

Table 2 Categorical Variables for Pimobendan Treatment Group

From: Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy

  Positive before and after pimobendan (n) Positive before and negative after pimobendan (n) Negative before and positive after pimobendan (n) Negative before and negative after pimobendan (n) P value
Level 1 LVOTO3 (Vmax > 1.9 m/s) 10 0 7 4 0.02
Level 2 LVOTO3 (Vmax > 2.74 m/s) 5 0 3 13 0.25
SAM3 9 0 5 7 0.07
Mid-LVOTO3 3 1 7 10 0.08
RVOTO3 9 0 10 2 0.004
VPCs3 1 3 2 15 1.00
Murmur3 18 0 2 1 0.50
  1. 3McNemar Test
  2. LVOTO, left ventricular outflow tract obstruction; SAM, systolic anterior motion of the mitral valve; DRVOTO, dynamic right ventricular outflow tract obstruction; VPCs, ventricular premature complexes